Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
752 Developing biomarkers for bexmarilimab, a novel macrophage-guided immunotherapy, in advanced solid tumors to select patients and confirm mechanism of action
Compose a Response to This Article
Other responses
No responses have been published for this article.
